P-343 The impact of genomic alterations on response rate and survival outcomes in advanced BTC patients who receive cisplatin/gemcitabine plus durvalumab in clinical practice
| Autor: | Rimini, M., Rizzato, M., Rimassa, L., Niger, M., Fornaro, L., Antonuzzo, L., Martinelli, E., Garajová, I., Pastorino, A., Giordano, G., Schirripa, M., Silletta, M., Diana, A., Gardini, A. Casadei |
|---|---|
| Zdroj: | In Annals of Oncology June 2023 34 Supplement 1:S135-S135 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|